21323-71-7 Usage
Uses
Used in Pharmaceutical Development:
7-chloro-3-methyl-3H-1,2,3-triazolo(4,5-d)pyrimidine is utilized as a potential drug candidate for its anti-inflammatory and anti-cancer properties. Its unique structure allows it to modulate biological pathways involved in inflammation and cancer progression, offering a new avenue for therapeutic intervention in these conditions.
Used in Organic Synthesis:
In the field of organic synthesis, 7-chloro-3-methyl-3H-1,2,3-triazolo(4,5-d)pyrimidine serves as a valuable building block for the creation of other chemical compounds. Its reactivity and structural features make it a useful component in the synthesis of a variety of organic molecules, expanding the scope of chemical research and development.
Used in Medicinal Chemistry Research:
7-chloro-3-methyl-3H-1,2,3-triazolo(4,5-d)pyrimidine is employed as a lead compound in medicinal chemistry research. Its exploration for biological activities and potential therapeutic applications contributes to the advancement of knowledge in drug discovery and the development of novel pharmaceuticals.
Used in Chemical Compound Design:
As a heterocyclic compound with distinct structural elements, 7-chloro-3-methyl-3H-1,2,3-triazolo(4,5-d)pyrimidine is used in the design of new chemical compounds. Its incorporation into various molecular frameworks can lead to the discovery of innovative materials and substances with diverse applications across different industries.
Check Digit Verification of cas no
The CAS Registry Mumber 21323-71-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,1,3,2 and 3 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 21323-71:
(7*2)+(6*1)+(5*3)+(4*2)+(3*3)+(2*7)+(1*1)=67
67 % 10 = 7
So 21323-71-7 is a valid CAS Registry Number.
InChI:InChI=1/C5H4ClN5/c1-11-5-3(9-10-11)4(6)7-2-8-5/h2H,1H3
21323-71-7Relevant academic research and scientific papers
Heterocyclic Compounds Useful as RAF Kinase Inhibitors
-
Page/Page column 21, (2009/01/24)
The present invention provides compounds useful as inhibitors of Raf protein kinase. The present invention also provides compositions thereof, and methods of treating Raf-mediated diseases.
Compounds containing a N-heteroaryl moiety linked to fused ring moieties for the inhibition of NAD(P)H oxidases and platelet activation
-
Page/Page column 91, (2008/06/13)
The invention relates to compounds containing a N-heteroaryl moiety, which is linked via oxygen, sulfur or nitrogen, or via a methylene bridge and oxygen, sulfur or nitrogen to a fused ring moiety, in particular to the 1,2,3-triazolo[4,5-d]pyrimidine-7-yl radical. The invention also relates to a process for the preparation of said compounds and the use thereof in drugs for the treatment of NAD(P)H oxidases-related diseases and disorders and inhibition of platelet activation.
